← Back to headlines
Mayne Pharma Reports Higher Margins in Second Half of Fiscal 2026
Pharmaceutical company Mayne Pharma announced improved profit margins during the second half of fiscal 2026, highlighting operational efficiencies and strong product performance.
27 Aug, 00:23 — 27 Aug, 00:23
Sources
Showing 1 of 1 sources
Related Stories
Volkswagen Approves Major Restructuring Plan Targeting 100,000 Jobs
27m ago
Trump Administration Seeks Supreme Court Approval for Mail Ballot Restrictions
50m ago
New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism
51m ago
Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal
55m ago